CryoTherapeutics SA
PrivateLast Round
Series B
Extension
Apr 2, 2024
Total Funding Raised
$47.19M
Company Overview
CryoTherapeutics SA operates in Healthcare & Life Sciences and is based in Awans. Its latest recorded funding round was a Series B Extension round in April 2024.
CryoTherapeutics SA is a medical device company developing a catheter-based cryotherapy system designed to treat atherosclerotic plaque that causes heart attacks by delivering cryoenergy to the coronary arteries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CryoTherapeutics SA Comparables
Compare CryoTherapeutics SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prescient Medical, Inc. | 79% | |
| Miracor Medical SA | 73% | |
| Corflow | 72% |
For institutional investors. Book with your work email.
CryoTherapeutics SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 2, 2024 | ||||
| Series B | Feb 17, 2022 | ||||
| Series B | Jun 27, 2019 | ||||
| Series B | Jul 7, 2016 | ||||
| Series A Extension | May 6, 2014 | ||||
Series A | Mar 21, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CryoTherapeutics SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | Series B, Series B Extension |
| Getz Brothers | Series B, Series A, Series A Extension |
| Yellowstone Holding AG | Series B, Series B Extension |
| NRW.Bank | Series A, Series B, Series B Extension, Series A Extension |
| Creathor Venture | Series B |
| GED Ventures Portugal | Series B Extension |
| Peppermint Venture Partners | Series B, Series A, Series B Extension, Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 21, 2025
Launched ICECAP in partnership with SpectraWAVE and CRF.
- Nov 21, 2025
Partnered with SpectraWAVE and CRF to launch ICECAP.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 25, 2026
Cryotherapeutics is developing an investigational catheter-based cryotherapy system in Belgium that delivers localized cooling to image-identified, non-obstructive coronary plaques without permanent implants.
For institutional investors. Book with your work email.
CryoTherapeutics SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CryoTherapeutics SA's valuation, stock price, and market status.
Is CryoTherapeutics SA a public or private company?
CryoTherapeutics SA is a private company.
What is the current stock price of CryoTherapeutics SA?
CryoTherapeutics SA is a private company, so its shares have no public market price. Caplight tracks CryoTherapeutics SA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CryoTherapeutics SA worth (valuation)?
Valuation information for CryoTherapeutics SA is not publicly available.
Can I buy CryoTherapeutics SA stock?
CryoTherapeutics SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CryoTherapeutics SA's last funding round?
CryoTherapeutics SA's most recent funding round was Series B Extension on April 2, 2024.
Who are the main investors in CryoTherapeutics SA?
Key investors in CryoTherapeutics SA include Noshaq, Creathor Venture, Peppermint Venture Partners.
Will CryoTherapeutics SA IPO soon?
No public IPO plans have been announced for CryoTherapeutics SA.
How can I track CryoTherapeutics SA secondary market activity?
Caplight tracks bids, offers, and trades in CryoTherapeutics SA's shares on secondary markets.